| RS145751759 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1457520634 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Cystic fibrosis |
| RS1457522002 |
SLC39A4
|
Health Risk |
Pathogenic |
— |
| RS145752649 |
RASA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Capillary malformation-arteriovenous malformation 1, Capillary malformation-arteriovenous malformation syndrome |
| RS145753633 |
SPTB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS145754381 |
ABCG8
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, ABCG8-related disorder |
| RS145754397 |
KAT6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, KAT6A-related disorder |
| RS145754412 |
SARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperuricemia, pulmonary hypertension |
| RS145754440 |
ARHGEF10
|
Health Risk |
Conflicting classifications of pathogenicity |
ARHGEF10-related disorder, ARHGEF10-related disorder |
| RS145754558 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS145754721 |
EFHC1
|
Health Risk |
Conflicting classifications of pathogenicity |
EFHC1-related disorder, Absence seizure |
| RS145755198 |
COL5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS145755269 |
TRPM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial heart block type IB, Cardiovascular phenotype |
| RS1457558516 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, FLNC-related disorder |
| RS145756629 |
BMPR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Generalized juvenile polyposis/juvenile polyposis coli |
| RS145756948 |
PDE6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stationary night blindness autosomal dominant 2, Retinitis pigmentosa |
| RS145757313 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS145757452 |
TMC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 7, Autosomal dominant nonsyndromic hearing loss 36 |
| RS1457574807 |
HNF1B
|
Health Risk |
Likely pathogenic |
Renal cysts and diabetes syndrome, Renal cysts and diabetes syndrome |
| RS145758016 |
EVC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS145758069 |
HMCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Age related macular degeneration 1, Age related macular degeneration 1 |
| RS1457582183 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome |
| RS145758265 |
HUWE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, HUWE1-related disorder |
| RS145758711 |
PDSS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS145758886 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1457594219 |
LZTR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS145759442 |
RNF13
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS145759514 |
C1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS145759754 |
VPS33B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS145760297 |
HECW2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with hypotonia, seizures |
| RS1457604010 |
TBX3
|
Health Risk |
Pathogenic |
TBX3-related disorder, TBX3-related disorder |
| RS145760682 |
NBEAL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Gray platelet syndrome, NBEAL2-related disorder |
| RS1457607996 |
ASL
|
Health Risk |
Pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1457613214 |
EXT2
|
Health Risk |
Likely pathogenic |
Seizures-scoliosis-macrocephaly syndrome, Mesothelioma |
| RS145761354 |
APOA4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1457616370 |
FBXL4
|
Health Risk |
Pathogenic |
— |
| RS145762491 |
FANCI
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group I |
| RS145762575 |
ALG9
|
Health Risk |
Conflicting classifications of pathogenicity |
ALG9 congenital disorder of glycosylation, ALG9-related disorder |
| RS145762716 |
GLMN
|
Health Risk |
Conflicting classifications of pathogenicity |
Glomuvenous malformation, Blue rubber bleb nevus |
| RS1457631500 |
FANCC
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Hereditary cancer-predisposing syndrome |
| RS145763979 |
EMC1
|
Health Risk |
Likely pathogenic |
— |
| RS1457643740 |
FOXF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS145764920 |
WRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Werner syndrome, Werner syndrome |
| RS1457662393 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, King Denborough syndrome |
| RS1457666982 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Mitochondrial complex II deficiency |
| RS1457667479 |
POMGNT1
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3 |
| RS145766755 |
UPB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of beta-ureidopropionase, Deficiency of beta-ureidopropionase |
| RS145766839 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS145766983 |
SACS
|
Health Risk |
Pathogenic/Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS1457671346 |
PLOD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS145767631 |
SH3PXD2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Frank-Ter Haar syndrome, Frank-Ter Haar syndrome |
| RS145768205 |
PCLO
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1457697672 |
AP3B1
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS145769847 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS145770066 |
MED25
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2B2, Charcot-Marie-Tooth disease |
| RS145770391 |
PCSK9
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypercholesterolemia, Hypercholesterolemia |
| RS145770544 |
CRYBB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cataract 22 multiple types, Inborn genetic diseases |
| RS145771233 |
APOC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial apolipoprotein C-II deficiency, Cardiovascular phenotype |
| RS145771389 |
TRPM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial heart block type IB, Cardiovascular phenotype |
| RS145771708 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS1457725246 |
KIZ
|
Health Risk |
Pathogenic |
— |
| RS145773486 |
GBA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gaucher disease type I, Gaucher disease type I |
| RS145774130 |
STX11
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemophagocytic lymphohistiocytosis 4, STX11-related disorder |
| RS1457743720 |
STRC
|
Health Risk |
Likely pathogenic |
Rare genetic deafness, Rare genetic deafness |
| RS145774400 |
NLRP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cryopyrin associated periodic syndrome, Cryopyrin associated periodic syndrome |
| RS1457746213 |
COL11A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fibrochondrogenesis 2, Otospondylomegaepiphyseal dysplasia |
| RS1457748796 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS145775350 |
CLCN7
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteopetrosis, Osteopetrosis |
| RS145776235 |
IFT80
|
Health Risk |
Conflicting classifications of pathogenicity |
Jeune thoracic dystrophy, Asphyxiating thoracic dystrophy 2 |
| RS1457762802 |
PDX1
|
Health Risk |
Uncertain risk allele |
Pancreatic hypoplasia, Pancreatic hypoplasia |
| RS145776307 |
LRIT3
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stationary night blindness 1F, Congenital stationary night blindness 1F |
| RS145776973 |
PEX13
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 11A (Zellweger), PEX13-related disorder |
| RS145777339 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS145777402 |
OTC
|
Health Risk |
Pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS1457774840 |
ACSF3
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined malonic and methylmalonic acidemia, Combined malonic and methylmalonic acidemia |
| RS1457778017 |
MSH3
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 4, Familial adenomatous polyposis 4 |
| RS145778165 |
PHEX
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Intellectual disability |
| RS1457784654 |
ALDH3A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Sjögren-Larsson syndrome, Sjögren-Larsson syndrome |
| RS145778937 |
GLI2
|
Health Risk |
Conflicting classifications of pathogenicity |
Holoprosencephaly 9, Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome |
| RS145779113 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS1457793607 |
AHI1
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS1457802163 |
ASPA
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1457806589 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Early-infantile DEE |
| RS145780832 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS145781920 |
LAMA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Retinal dystrophy |
| RS145782750 |
POR
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis |
| RS1457831101 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS145784441 |
SLC12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bartter disease type 1, Bartter disease type 1 |
| RS145785230 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS145785746 |
FOXI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 4, Autosomal recessive nonsyndromic hearing loss 4 |
| RS1457860223 |
SLC5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital glucose-galactose malabsorption, Congenital glucose-galactose malabsorption |
| RS145786060 |
DNAJC19
|
Health Risk |
Pathogenic |
3-methylglutaconic aciduria type 5, 3-Methylglutaconic aciduria type 3 |
| RS145786485 |
EVC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS145786786 |
AMPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscle AMP deaminase deficiency, AMPD1-related disorder |
| RS145786819 |
AMACR
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha-methylacyl-CoA racemase deficiency, AMACR-related disorder |
| RS1457869893 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS145787161 |
LDLR
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypercholesterolemia, familial |
| RS1457875051 |
GALE
|
Health Risk |
Conflicting classifications of pathogenicity |
UDPglucose-4-epimerase deficiency, Thrombocytopenia 13 |
| RS145787667 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS145787738 |
DAAM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizure, Seizure |